Stay updated on Nivolumab in Untreated Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab in Untreated Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page’s application/software revision indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site update rather than a change to the study record.SummaryDifference0.0%

- Check20 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check28 days agoChange DetectedNew update entries dated 2026-04-06, 2026-03-17, and 2026-03 were added, while entries from 2025-03-05, 2025-02-26, and 2025-02 were removed.SummaryDifference0.2%

- Check50 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2 release.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded Revision: v3.4.2. Removed the funding-lapse notice and Revision: v3.4.1.SummaryDifference0.3%

Stay in the know with updates to Nivolumab in Untreated Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Untreated Lung Cancer Clinical Trial page.